Elanco Animal Health Inc (ELAN)
13.46
+0.52
(+4.06%)
USD |
NYSE |
Apr 23, 16:00
13.46
0.00 (0.00%)
After-Hours: 17:18
Elanco Animal Health Shareholders Equity (Quarterly): 6.223B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.223B |
| September 30, 2023 | 6.134B |
| June 30, 2023 | 7.42B |
| March 31, 2023 | 7.48B |
| December 31, 2022 | 7.289B |
| September 30, 2022 | 6.745B |
| June 30, 2022 | 7.14B |
| March 31, 2022 | 7.612B |
| December 31, 2021 | 7.508B |
| September 30, 2021 | 7.682B |
| June 30, 2021 | 7.98B |
| March 31, 2021 | 8.007B |
| Date | Value |
|---|---|
| December 31, 2020 | 8.476B |
| September 30, 2020 | 8.344B |
| June 30, 2020 | 6.652B |
| March 31, 2020 | 6.662B |
| December 31, 2019 | 5.547B |
| September 30, 2019 | 5.488B |
| June 30, 2019 | 5.266B |
| March 31, 2019 | 5.196B |
| December 31, 2018 | 5.198B |
| September 30, 2018 | 5.137B |
| June 30, 2018 | 7.587B |
| December 31, 2017 | 7.780B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
5.266B
Minimum
Jun 2019
8.476B
Maximum
Dec 2020
7.034B
Average
7.289B
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co Inc | 37.58B |
| Catalent Inc | 3.687B |
| NanoString Technologies Inc | -50.57M |
| Cytokinetics Inc | -386.32M |
| Geron Corp | 247.95M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.36B |
| Total Liabilities (Quarterly) | 8.139B |
| Debt to Equity Ratio | 0.9278 |
| Current Ratio | 2.745 |
| Net Debt Paydown Yield | 0.35% |